SCHEMBL4379558

SCHEMBL4379558

CCN(CC)Cc1cccc(-c2c[nH]c(=O)c(-c3ccccc3C#N)c2-c2ccccc2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.36
ADORA1 P30542 1/20 0.36
MCL1 Q07820 3/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MDM2 Q00987 1/20 0.34
TSHR P16473 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
GALR3 O60755 1/20 0.33
GAA P10253 1/20 0.33
KDM5A P29375 2/20 0.32
POLB P06746 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
CTSB P07858 1/20 0.32
CTSA P10619 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3677714 0.82 TGFBR1 (0.42) MCL1ALDH1A1HPGDKDM4EMDM2
SCHEMBL3666760 0.81 MCL1 (0.41) MCL1ALDH1A1HPGDKDM4EMDM2
SCHEMBL2921713 0.79 SLC6A2 (0.41) MCL1ALDH1A1HPGDKDM4EMDM2
SCHEMBL2763451 0.78 MCL1 (0.36) ADORA2AADORA1MCL1ALDH1A1HPGD
Water SCHEMBL4777584 0.76 GRIA1 (0.47) MCL1ALDH1A1HPGDKDM4EMDM2
SCHEMBL2918049 0.76 GRIA1 (0.47) MCL1ALDH1A1HPGDKDM4EMDM2
SCHEMBL3672706 0.73 KDM4E (0.40) MCL1ALDH1A1HPGDKDM4EMDM2
SCHEMBL3802043 0.73 LRRK2 (0.45) ADORA2A
SCHEMBL6674051 0.72 PARP1 (0.39) MCL1
SCHEMBL6686812 0.72 GRIA1 (0.47) MCL1ALDH1A1HPGDKDM4EMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2053041-A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease Eisai R&D Management Co., Ltd. (JP) 2009-04-29 EP disclosed